(GoodRx) A New Medicare Option for Weight-Loss Drugs Is Coming (NPR)
These therapies, initially designed for type 2 diabetes, have demonstrated significant weight loss benefits, leading to their expanded use in obesity management
Research Insights Sleep and Circadian Regulation Studies suggest DSIPs role in improving sleep quality and structure, especially in individuals with chronic insomnia ( 1, 2 )
The biocompatibility, targeting, and release mechanisms of nanoparticles need to be further studied, and the safety and efficacy of CRISPR technology in periodontal therapy, especially in avoiding genetic variation, need to be further explored
HrbjartssonABoutronITurnerLAltmanDGMoherD
Safety monitoring also required a longer-term perspective